Pregled bibliografske jedinice broj: 1207039
Spectrum of radiological imaging findings of immune-checkpoint blockade for lung cancer at University hospital centre Osijek
Spectrum of radiological imaging findings of immune-checkpoint blockade for lung cancer at University hospital centre Osijek // Libri Oncologici : Croatian Journal of Oncology, vol.50, Suppl.1
Opatija, Hrvatska, 2022. str. 142-143 (poster, međunarodna recenzija, sažetak, stručni)
CROSBI ID: 1207039 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Spectrum of radiological imaging findings of
immune-checkpoint blockade for lung cancer at
University hospital centre Osijek
Autori
Krivdić Dupan, Zdravka ; Canjko, Ivana ; Guljaš, Silva ; Šarić, Gordan ; Šambić Penc, Mirela ; Prlić- Seršić, Ingrid ; Dumačić, Dijana
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, stručni
Izvornik
Libri Oncologici : Croatian Journal of Oncology, vol.50, Suppl.1
/ - , 2022, 142-143
Skup
15. hrvatski onkološki kongres (HOK 2022)
Mjesto i datum
Opatija, Hrvatska, 31.03.2022. - 03.04.2022
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
hyperprogression ; NSCLC ; PD-L1 pseudoprogression
Sažetak
Cancer immunotherapy based on immune-checkpoint blockade has resulted in yet another paradigm shift in advanced cancer treatment.ICIs block tumor-induced immune inhibitionand thereby activate cellular immune response against tumors. Programmed death-1 (PD-1) and programmed death- ligand 1 (PD-L1) inhibitors are two major groups of agents used in the treatment of advanced NSCLC. Prior to ICIs introduction, the mainstay of treatment for patients with advanced NSCLC who had no targetable mutations was cytotoxic chemotherapy, but without meaningful improvement in outcomes.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Klinički bolnički centar Osijek,
Medicinski fakultet, Osijek
Citiraj ovu publikaciju:
Časopis indeksira:
- Scopus